Reference
Health Products Regulatory Authority. Ibuprofen-containing medicines : Potential risk of Acute Generalised Exanthematous Pustulosis. Internet Document : 3 Mar 2022. Available from: URL: https://www.hpra.ie/docs/default-source/default-document-library/imf_march-2022_ibuprofen.pdf?sfvrsn=0
Rights and permissions
About this article
Cite this article
Ireland's HPRA updates product information for ibuprofen to include rare skin reaction. Reactions Weekly 1897, 4 (2022). https://doi.org/10.1007/s40278-022-11241-2
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-022-11241-2